Healthcare provider profile · identity verified

Steven Boehmer, DO

General Practice · BURLEY, ID · NPI 1336563063

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	261	81
Levothyroxine Sodium	Levothyroxine Sodium	239	67
Omeprazole	Omeprazole	192	60
Hydrochlorothiazide	Hydrochlorothiazide	188	53
Lisinopril	Lisinopril	166	49
Metformin Hcl Er	Metformin Hcl	155	55
Losartan Potassium	Losartan Potassium	146	44
Amlodipine Besylate	Amlodipine Besylate	128	40
Tamsulosin Hcl	Tamsulosin Hcl	108	34
Simvastatin	Simvastatin	94	28
Metoprolol Succinate	Metoprolol Succinate	89	29
Gabapentin	Gabapentin	88	27
Rosuvastatin Calcium	Rosuvastatin Calcium	72	20
Spironolactone	Spironolactone	68	20
Metformin Hcl	Metformin Hcl	65	22
Furosemide	Furosemide	64	21
Enalapril Maleate	Enalapril Maleate	62	16
Tramadol Hcl	Tramadol Hcl	61	14
Albuterol Sulfate Hfa	Albuterol Sulfate	58	18
Glimepiride	Glimepiride	58	13
Paroxetine Hcl	Paroxetine Hcl	58	15
Trazodone Hcl	Trazodone Hcl	57	16
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	54	18
Eliquis	Apixaban	53	16
Meloxicam	Meloxicam	53	19
Pantoprazole Sodium	Pantoprazole Sodium	52	15
Fluoxetine Hcl	Fluoxetine Hcl	51	15
Fluticasone Propionate	Fluticasone Propionate	50	15
Allopurinol	Allopurinol	49	16
Citalopram Hbr	Citalopram Hydrobromide	48	15
Ropinirole Hcl	Ropinirole Hcl	48	suppressed
Potassium Chloride	Potassium Chloride	44	20
Alendronate Sodium	Alendronate Sodium	41	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	41	35
Carvedilol	Carvedilol	41	12
Metoprolol Tartrate	Metoprolol Tartrate	41	15
Sertraline Hcl	Sertraline Hcl	40	15
Chlorthalidone	Chlorthalidone	38	13
Pioglitazone Hcl	Pioglitazone Hcl	38	13
Finasteride	Finasteride	35	12
Estradiol	Estradiol	34	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	33	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Trulicity	Dulaglutide	32	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	30	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Montelukast Sodium	Montelukast Sodium	29	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	28	21
Zolpidem Tartrate	Zolpidem Tartrate	28	suppressed
Celecoxib	Celecoxib	27	suppressed
Ezetimibe	Ezetimibe	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Diazepam	Diazepam	24	suppressed
Ozempic	Semaglutide	23	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	23	suppressed
Prednisone	Prednisone	23	17
Lorazepam	Lorazepam	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	21	suppressed
Spiriva Respimat	Tiotropium Bromide	21	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	20	19
Jardiance	Empagliflozin	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Clonazepam	Clonazepam	18	suppressed
Breyna	Budesonide/Formoterol Fumarate	17	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	14
Xarelto	Rivaroxaban	17	suppressed
Cephalexin	Cephalexin	15	suppressed
Duloxetine Hcl	Duloxetine Hcl	15	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	14	11
Enalapril-Hydrochlorothiazide	Enalapril/Hydrochlorothiazide	13	suppressed
Memantine Hcl	Memantine Hcl	13	suppressed
Benazepril Hcl	Benazepril Hcl	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Clotrimazole	Clotrimazole	12	suppressed
Colesevelam Hcl	Colesevelam Hcl	12	suppressed
Fenofibrate	Fenofibrate	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Linzess	Linaclotide	12	suppressed
Lurasidone Hcl	Lurasidone Hcl	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Restasis	Cyclosporine	11	suppressed
Topiramate	Topiramate	11	suppressed
Tresiba Flextouch U-100	Insulin Degludec	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error